4//SEC Filing
Priebe Waldemar 4
Accession 0001144204-17-044232
CIK 0001659617other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 6:00 PM ET
Size
5.5 KB
Accession
0001144204-17-044232
Insider Transaction Report
Form 4
Priebe Waldemar
10% Owner
Transactions
- Sale
Common Stock
2017-08-16$1.70/sh−100,000$170,300→ 2,781,573 total
Footnotes (2)
- [F1]The reporting person entered into a private sale agreement for the shares of common stock set forth in the table.
- [F2]In addition to the shares held directly by the reporting person, The reporting person is a shareholder and control person of IntertechBio Corp. IntertechBio Corp. holds 630,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by IntertechBio Corp. The reporting person is also a shareholder and control person of Houston Pharmaceuticals, Inc. Houston Pharmaceuticals, Inc. holds 629,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Houston Pharmaceuticals, Inc.
Documents
Issuer
Moleculin Biotech, Inc.
CIK 0001659617
Entity typeother
Related Parties
1- filerCIK 0001678516
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 6:00 PM ET
- Size
- 5.5 KB